RP Management, LLC - Q3 2021 holdings

$214 Million is the total value of RP Management, LLC's 4 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 0.0% .

 Value Shares↓ Weighting
BHVN  BIOHAVEN PHARMACTL HLDG CO L$154,344,000
+43.1%
1,111,1110.0%72.03%
+37.0%
EPZM  EPIZYME INC$46,933,000
-38.4%
9,166,6670.0%21.90%
-41.0%
BuyEPIZYME INCcall$12,964,000
-38.3%
2,532,048
+0.2%
6.05%
-40.9%
VIRX  VIRACTA THERAPEUTICS INC$30,000
-28.6%
3,7000.0%0.01%
-30.0%
Other managers

Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):

Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2021-11-15
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
BIOHAVEN PHARMACTL HLDG CO L16Q3 202277.6%
EPIZYME INC11Q2 202244.1%
EPIZYME INC11Q2 202213.9%
VIRACTA THERAPEUTICS INC11Q3 20235.7%
CYTOKINETICS INC10Q1 20217.6%
SUNESIS PHARMACEUTICALS INC9Q4 20200.1%
IMMUNOMEDICS INC8Q3 202055.7%
BIOCRYST PHARMACEUTICALS INC8Q3 202352.0%
BIOHAVEN LTD4Q3 202373.7%

View RP Management, LLC's complete holdings history.

Latest significant ownerships (13-D/G)
RP Management, LLC Q3 2021 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
CYPRESS BIOSCIENCE INCDecember 23, 20103,815,0009.9%

View RP Management, LLC's complete significant-ownership history.

Latest filings
TypeFiled
13F-HR2024-02-13
13F-HR2023-11-13
13F-HR2023-08-11
13F-HR2023-05-15
13F-HR2023-02-14
13F-HR2022-11-14
42022-08-16
13F-HR2022-08-10
42022-05-19
13F-HR2022-05-11

View RP Management, LLC's complete filings history.

Compare quarters

Export RP Management, LLC's holdings